Institutional investors purchased a net $1.7 million shares of OREX during the quarter ended September 2017, and now own 39.34% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GLG LLC Bought 1.5 Million shares of Orexigen Therapeutics Inc